Onconetix

ONCONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.291 M

$0.89 -1.34%

Close of 7 Aug 2026

Revenue

$815.4K

#3516 by revenue

Earnings

-$14.0M

Loss-making

Shares outstanding

3,584,245

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#483XORTX TherapeuticsXRTX$3.69M
#484RedHill BiopharmaRDHL$3.68M
#485OnconetixONCO$3.29M
#48660 Degrees PharmaceuticalsSXTP$3.19M
#487PRF TechnologiesPRFX$3.16M

Where these numbers come from

Share counts and financials for Onconetix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.